The first known epidemic of dengue hemorrhagic fever was recorded in Manila in 1953. Since then, dengue has become a year-round threat in the Philippines.
This mosquito-borne disease reported an average of 220 cases daily
The first known epidemic of dengue hemorrhagic fever was recorded in Manila in 1953. Since then, dengue has become a year-round threat in the Philippines.
This mosquito-borne disease reported an average of 220 cases daily in 2015, half of this came from Region 3, Region 4 and the National Capital Region. Millions worldwide have died because there was no specific anti-viral treatment that exists. Instead, preventive measures are imposed to the public through maintaining cleanliness in one’s surroundings: proper waste disposal, removing artificial man-made mosquito habitats, covering and cleaning domestic water storage containers and using personal and household protection.
Through years of research, the world’s first dengue vaccine has been developed to help control this infectious disease. Here are some facts from a roundtable discussion I have recently attended, shared by Dr. Alain Bouckenooghe (head of Research and Development, Sanofi Pasteur) and Dr. Joshua Nealon (head of epidemiology for Asia Pacific, Sanofi Pasteur).
What is the name of the dengue vaccine and who manufactured it?
Sanofi Pasteur’s dengue vaccine, Dengvaxia (also referred to as CYD-TDV), is the first vaccine licensed for the prevention of dengue in the world.
Whic